IOL CHEMICALS & PHARM. | GLENMARK LIFE SCIENCES | IOL CHEMICALS & PHARM./ GLENMARK LIFE SCIENCES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.8 | 19.5 | 70.7% | View Chart |
P/BV | x | 1.6 | 4.7 | 33.0% | View Chart |
Dividend Yield | % | 1.0 | 2.5 | 39.0% |
IOL CHEMICALS & PHARM. GLENMARK LIFE SCIENCES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
GLENMARK LIFE SCIENCES Mar-23 |
IOL CHEMICALS & PHARM./ GLENMARK LIFE SCIENCES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 534 | 100.5% | |
Low | Rs | 272 | 369 | 73.8% | |
Sales per share (Unadj.) | Rs | 377.6 | 176.4 | 214.1% | |
Earnings per share (Unadj.) | Rs | 23.7 | 38.1 | 62.2% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 41.5 | 76.0% | |
Dividends per share (Unadj.) | Rs | 4.00 | 21.00 | 19.0% | |
Avg Dividend yield | % | 1.0 | 4.7 | 21.3% | |
Book value per share (Unadj.) | Rs | 256.8 | 174.0 | 147.6% | |
Shares outstanding (eoy) | m | 58.71 | 122.53 | 47.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.6 | 41.8% | |
Avg P/E ratio | x | 17.1 | 11.8 | 144.0% | |
P/CF ratio (eoy) | x | 12.8 | 10.9 | 117.9% | |
Price / Book Value ratio | x | 1.6 | 2.6 | 60.7% | |
Dividend payout | % | 16.9 | 55.1 | 30.6% | |
Avg Mkt Cap | Rs m | 23,743 | 55,321 | 42.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 1,802 | 93.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 21,612 | 102.6% | |
Other income | Rs m | 256 | 290 | 88.4% | |
Total revenues | Rs m | 22,427 | 21,902 | 102.4% | |
Gross profit | Rs m | 2,257 | 6,423 | 35.1% | |
Depreciation | Rs m | 462 | 421 | 109.7% | |
Interest | Rs m | 165 | 5 | 3,011.0% | |
Profit before tax | Rs m | 1,887 | 6,286 | 30.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 1,616 | 30.6% | |
Profit after tax | Rs m | 1,391 | 4,670 | 29.8% | |
Gross profit margin | % | 10.2 | 29.7 | 34.2% | |
Effective tax rate | % | 26.2 | 25.7 | 102.1% | |
Net profit margin | % | 6.3 | 21.6 | 29.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 23,687 | 40.8% | |
Current liabilities | Rs m | 5,025 | 10,228 | 49.1% | |
Net working cap to sales | % | 20.9 | 62.3 | 33.6% | |
Current ratio | x | 1.9 | 2.3 | 83.1% | |
Inventory Days | Days | 43 | 2 | 2,679.3% | |
Debtors Days | Days | 8 | 136 | 6.1% | |
Net fixed assets | Rs m | 11,017 | 8,518 | 129.3% | |
Share capital | Rs m | 587 | 245 | 239.6% | |
"Free" reserves | Rs m | 14,490 | 21,070 | 68.8% | |
Net worth | Rs m | 15,077 | 21,315 | 70.7% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 32,205 | 64.2% | |
Interest coverage | x | 12.5 | 1,150.2 | 1.1% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.7 | 159.7% | |
Return on assets | % | 7.5 | 14.5 | 51.8% | |
Return on equity | % | 9.2 | 21.9 | 42.1% | |
Return on capital | % | 13.6 | 29.5 | 46.1% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 9,691 | 61.2% | |
Fx outflow | Rs m | 6,052 | 5,001 | 121.0% | |
Net fx | Rs m | -122 | 4,689 | -2.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 3,134 | 39.0% | |
From Investments | Rs m | -1,200 | -1,541 | 77.8% | |
From Financial Activity | Rs m | -41 | -3,876 | 1.1% | |
Net Cashflow | Rs m | -18 | -2,283 | 0.8% |
Indian Promoters | % | 48.2 | 82.9 | 58.2% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 6.4 | 26.5% | |
FIIs | % | 1.4 | 5.0 | 27.9% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 17.2 | 302.1% | |
Shareholders | 130,003 | 156,183 | 83.2% | ||
Pledged promoter(s) holding | % | 0.0 | 9.5 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | GLENMARK LIFE SCIENCES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.71% | -0.26% | 1.03% |
1-Month | 6.55% | 8.86% | 1.10% |
1-Year | 1.45% | 76.88% | 53.75% |
3-Year CAGR | -12.66% | 3.32% | 14.67% |
5-Year CAGR | 16.39% | 1.98% | 19.26% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the GLENMARK LIFE SCIENCES share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of GLENMARK LIFE SCIENCES the stake stands at 82.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of GLENMARK LIFE SCIENCES.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
GLENMARK LIFE SCIENCES paid Rs 21.0, and its dividend payout ratio stood at 55.1%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of GLENMARK LIFE SCIENCES.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.